2021-01-08,Jounce Therapeutics to Present at Upcoming Investor Conferences in January
2020-12-23,Are Options Traders Betting on a Big Move in Jounce Therapeutics (JNCE) Stock?
2020-12-16,Jounce Therapeutics Added to NASDAQ Biotechnology Index
2020-12-11,Is JNCE A Good Stock To Buy Now?
2020-11-25,Jounce Therapeutics to Participate in a Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-16,Jounce Therapeutics Receives Study May Proceed Letter from US FDA to Initiate Phase 1 Clinical Trial of JTX-8064 Targeting the LILRB2/ILT4 Mechanism
2020-11-11,Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the Society for Immunotherapy of Cancers (SITC) 35th Annual Meeting
2020-11-09,Jounce Therapeutics to Participate in a Virtual Fireside Chat at Cowen 2020 IO Next Summit
2020-11-06,"Jounce Therapeutics, Inc. (JNCE) Q3 2020 Earnings Call Transcript"
2020-11-06,Jounce Therapeutics Reports Third Quarter 2020 Financial Results
2020-11-02,Why Jounce Therapeutics Stock Is Crashing Today
2020-11-02,Jounce Therapeutics Announces Update on Vopratelimab Program
2020-10-30,"Jounce Therapeutics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Friday, November 6, 2020"
2020-10-26,If You Had Bought Jounce Therapeutics (NASDAQ:JNCE) Shares A Year Ago You'd Have Earned 147% Returns
2020-09-22,"3 High-Risk, High-Reward Stocks to Add to Your Watch List"
2020-09-02,Jounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in September
2020-09-02,Gilead Inks Deal With Jounce to License an Oncology Candidate
2020-09-01,P/E Ratio Insights for Jounce Therapeutics
2020-09-01,"Gilead signs on for another oncology deal, this time with Jounce Therapeutics"
2020-09-01,Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
2020-09-01,Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
2020-08-07,Jounce Therapeutics Reports Second Quarter 2020 Financial Results
2020-08-04,Jounce Therapeutics to Participate in a Fireside Chat at BTIG Virtual Biotechnology Conference 2020
2020-07-31,"Jounce Therapeutics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Friday, August 7, 2020"
2020-07-28,"What Type Of Shareholders Make Up Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Share Registry?"
2020-07-05,"Should You Avoid Jounce Therapeutics, Inc. (JNCE)?"
2020-06-22,Jounce Therapeutics Presents First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at The American Association for Cancer Research Virtual Annual Meeting
2020-06-10,Jounce Therapeutics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference
2020-06-08,"Got $1,000? Buy These 4 Cancer Stocks"
2020-06-04,Jounce Therapeutics Regains Worldwide Rights to JTX-8064 from Bristol Myers Squibb
2020-06-02,Jounce Therapeutics to Hold Virtual Meeting of Stockholders
2020-05-15,Jounce Therapeutics to Present First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at the American Association for Cancer Research Virtual Annual Meeting
2020-05-09,"Earnings Update: Jounce Therapeutics, Inc. (NASDAQ:JNCE) Just Reported And Analysts Are Trimming Their Forecasts"
2020-05-06,"Jounce Therapeutics, Inc. (JNCE) Q1 2020 Earnings Call Transcript"
2020-05-06,Recap: Jounce Therapeutics Q1 Earnings
2020-05-06,Jounce Therapeutics Reports First Quarter 2020 Financial Results
2020-04-29,"Jounce Therapeutics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020"
2020-04-21,"Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?"
2020-02-27,New Strong Buy Stocks for February 27th
2020-02-27,Jounce Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-27,"Jounce Therapeutics, Inc. to Host Earnings Call"
2020-02-26,Jounce Therapeutics to Present at Upcoming Investor Conferences in March
2020-02-21,"Jounce Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020"
2020-02-21,"Is Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) CEO Salary Justified?"
2020-02-20,What's in Store for Jounce (JNCE) This Earnings Season?
2020-02-06,Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies
2020-01-23,"Jounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E., to its Board of Directors"
2020-01-09,Jounce Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
2020-01-07,"Is Jounce Therapeutics, Inc. (NASDAQ:JNCE) Worth US$7.9 Based On Its Intrinsic Value?"
2019-12-20,Is Jounce Therapeutics (JNCE) Stock Outpacing Its Medical Peers This Year?
2019-12-19,"Did Hedge Funds Drop The Ball On Jounce Therapeutics, Inc. (JNCE)?"
2019-12-19,Jounce Therapeutics to Present New Data on a Potential Predictive Biomarker from the Vopratelimab ICONIC Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting
2019-12-19,ImmunoGen (IMGN) Looks Good: Stock Adds 7.6% in Session
2019-12-19,5 Russell 2000 Stocks That Crushed the Index This Year
2019-12-18,Pacira's Late-Stage Study on Exparel Label Expansion Positive
2019-12-13,Assertio to Divest Shingles Pain Drug to Alvogen for $127.5M
2019-12-09,Edited Transcript of JNCE.O earnings conference call or presentation 7-Nov-19 1:00pm GMT
2019-12-06,"The Zacks Analyst Blog Highlights: Jounce Therapeutics, Forterra, Hibbett Sports, Foundation Building Materials and Orion Energy Systems"
2019-12-05,Is the Options Market Predicting a Spike in Jounce Therapeutics (JNCE) Stock?
2019-12-05,Small Business Optimism Rises Amid Trade Jitters: 5 Top Picks
2019-12-03,"Jounce Therapeutics, Inc. (JNCE) Shares March Higher, Can It Continue?"
2019-12-02,Top Ranked Momentum Stocks to Buy for December 2nd
2019-11-22,"The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical"
2019-11-21,Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD
2019-11-12,Value ETFs &amp; Stocks Offering Real Value: 5 Top Picks
2019-11-11,5 High-Beta ETFs &amp; Stocks for a Record Market
2019-11-11,New Strong Buy Stocks for November 11th
2019-11-07,"Jounce Therapeutics, Inc. (JNCE) Q3 Earnings and Revenues Surpass Estimates"
2019-11-07,Jounce Therapeutics Reports Third Quarter 2019 Financial Results
2019-11-05,Jounce Therapeutics to Present Safety and Preliminary Efficacy Data on JTX-4014 and a Trials in Progress Poster for the Vopratelimab EMERGE Study at the Society for Immunotherapy of Cancers (SITC) 34th Annual Meeting
2019-10-31,"Jounce Therapeutics to Announce Third Quarter 2019 Financial Results and Host Conference Call on Thursday, November 7, 2019"
2019-10-29,Top Ranked Value Stocks to Buy for October 29th
2019-10-21,"Introducing Jounce Therapeutics (NASDAQ:JNCE), The Stock That Dropped 35% In The Last Year"
2019-10-01,Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Cancers (SITC) 34th Annual Meeting
2019-09-17,Jounce Therapeutics Names Jacquelyn Fahey Sandell as Chief Legal Officer and Corporate Secretary
2019-09-05,Edited Transcript of JNCE.O earnings conference call or presentation 7-Aug-19 12:00pm GMT
2019-08-28,Jounce Therapeutics to Present at Upcoming Investor Conferences in September
2019-08-21,"Do Institutions Own Shares In Jounce Therapeutics, Inc. (NASDAQ:JNCE)?"
2019-08-07,"Jounce Therapeutics, Inc. (JNCE) Reports Q2 Loss, Tops Revenue Estimates"
2019-08-07,Jounce Therapeutics Reports Second Quarter 2019 Financial Results
2019-07-31,"Jounce Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019"
2019-07-24,What To Know About Jounce's Amended Licensing Deal With Celgene
2019-07-24,Biotech Stock Roundup: BIIB Q2 Earnings Top &amp; CELG's Otezla Label Expanded
2019-07-24,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index"
2019-07-23,Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
2019-07-12,Edited Transcript of JNCE.O earnings conference call or presentation 8-May-19 12:00pm GMT
2019-06-29,"Is Jounce Therapeutics, Inc. (JNCE) A Good Stock To Buy?"
2019-06-18,Jounce Therapeutics Initiates Phase 2 EMERGE Study of Vopratelimab in Combination with Ipilimumab in Patients with Non-Small Cell Lung Cancer or Urothelial Cancer
2019-06-11,Jounce Therapeutics to Present at Upcoming Investor Conferences in June
2019-05-23,"Estimating The Intrinsic Value Of Jounce Therapeutics, Inc. (NASDAQ:JNCE)"
2019-05-08,"Jounce Therapeutics, Inc. (JNCE) Reports Q1 Loss, Misses Revenue Estimates"
2019-05-08,Jounce Therapeutics Reports First Quarter 2019 Financial Results
2019-05-01,"Will Jounce Therapeutics, Inc. (JNCE) Report Negative Q1 Earnings? What You Should Know"
2019-05-01,"Jounce Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019"
2019-04-09,Here's Why Jounce Therapeutics Rose 39.3% in March
2019-04-03,Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the 2019 American Association for Cancer Research (AACR) Annual Meeting
2019-04-02,Jounce Therapeutics Reports Improved PFS and OS Associated with Vopratelimab (JTX-2011) Treatment Emergent Biomarker at the 2019 American Association for Cancer Research (AACR) Annual Meeting
2019-03-12,Investors Who Bought Jounce Therapeutics (NASDAQ:JNCE) Shares A Year Ago Are Now Down 80%
2019-03-08,Edited Transcript of JNCE.O earnings conference call or presentation 6-Mar-19 1:00pm GMT
2019-03-06,Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
